MARCKS signaling differentially regulates vascular smooth muscle and endothelial cell proliferation through a KIS-, p27kip1-dependent mechanism

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Yu, Dan ^a,b   Makkar, George ^b   Dong, Tuo ^a   Strickland, Dudley K ^a,b   Sarkar, Rajabrata ^a,b   Monahan, Thomas Stacey ^a,b  

^a BALTIMORE VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN MARCKS; REGULATOR PROTEIN; STATHMIN; UNCLASSIFIED DRUG; CCND1 PROTEIN, HUMAN; CCND1 PROTEIN, MOUSE; CDKN1B PROTEIN, HUMAN; CDKN1B PROTEIN, MOUSE; CYCLIN D1; MEMBRANE PROTEIN; MYRISTOYLATED ALANINE-RICH C KINASE SUBSTRATE; S PHASE KINASE ASSOCIATED PROTEIN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA INJURY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; BIOSYNTHESIS; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; S-PHASE KINASE-ASSOCIATED PROTEINS; SIGNAL TRANSDUCTION;

EID: 84951114981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141397     Document Type: Article

References (45)

1. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801. PMID: 15269336
2. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, Falk E (2006) Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 26: 2696-2702. PMID: 17008593
3. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115: 2435-2441. PMID: 17438147
4. Hayashi S, Yamamoto A, You F, Yamashita K, Ikegame Y, Tawada M, et al. (2009) The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol 175: 2226-2234. doi: 10.2353/ajpath.2009.090152 PMID: 19815708
5. Kalish JA, Willis DJ, Li C, Link JJ, Deutsch ER, Contreras MA, et al. (2004) Temporal genomics of vein bypass grafting through oligonucleotide microarray analysis. J Vasc Surg 39: 645-654. PMID: 14981462
6. Willis DJ, Kalish JA, Li C, Deutsch ER, Contreras MA, LoGerfo FW, et al. (2004) Temporal gene expression following prosthetic arterial grafting. J Surg Res 120: 27-36. PMID: 15172187
7. Monahan TS, Andersen ND, Martin MC, Malek JY, Shrikhande GV, Pradhan L, et al. (2009) MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein. FASEB J 23: 557-564. doi: 10.1096/fj.08-114173 PMID: 18940893
8. Disatnik MH, Boutet SC, Lee CH, Mochly-Rosen D, Rando TA (2002) Sequential activation of individual PKC isozymes in integrin-mediated muscle cell spreading: a role for MARCKS in an integrin signaling pathway. J Cell Sci 115: 2151-2163. PMID: 11973356
9. Ohmitsu M, Fukunaga K, Yamamoto H, Miyamoto E (1999) Phosphorylation of myristoylated alanine-rich protein kinase C substrate by mitogen-activated protein kinase in cultured rat hippocampal neurons following stimulation of glutamate receptors. J Biol Chem 274: 408-417. PMID: 9867858
10. Schonwasser DC, Palmer RH, Herget T, Parker PJ (1996) p42 MAPK phosphorylates 80 kDa MARCKS at Ser-113. FEBS Lett 395: 1-5. PMID: 8849678
11. Browne BC, Hochgrafe F, Wu J, Millar EK, Barraclough J, Stone A, et al. (2013) Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. FEBS J 280: 5237-5257. doi: 10.1111/febs.12441 PMID: 23876235
12. Techasen A, Loilome W, Namwat N, Takahashi E, Sugihara E, Puapairoj A, et al. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Cancer Sci 101: 658-665. doi: 10.1111/j.1349-7006.2009.01427.x PMID: 20047593
13. Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, et al. (2005) Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. Int J Oncol 26: 661-671. PMID: 15703821
14. Gardner-Thorpe J, Ito H, Ashley SW, Whang EE (2002) Differential display of expressed genes in pancreatic cancer cells. Biochem Biophys Res Commun 293: 391-395. PMID: 12054612
15. Bickeboller M, Tagscherer KE, Kloor M, Jansen L, Chang-Claude J, Brenner H, et al. (2015) Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival. Oncogene 34: 1150-1159. doi: 10.1038/onc.2014.40 PMID: 24662837
16. Li T, Li D, Sha J, Sun P, Huang Y (2009) MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 383: 280-285. doi: 10.1016/j.bbrc.2009.03.077 PMID: 19302977
17. Jarboe JS, Anderson JC, Duarte CW, Mehta T, Nowsheen S, Hicks PH, et al. (2012) MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma. Clin Cancer Res 18: 3030-3041. doi: 10.1158/1078-0432.CCR-11-3091 PMID: 22619307
18. Brooks G, Brooks SF, Goss MW (1996) MARCKS functions as a novel growth suppressor in cells of melanocyte origin. Carcinogenesis 17: 683-689. PMID: 8625478
19. Lee JG, Song JS, Smith RE, Kay EP (2011) Human corneal endothelial cells employ phosphorylation of p27(Kip1) at both Ser10 and Thr187 sites for FGF-2-mediated cell proliferation via PI 3-kinase. Invest Ophthalmol Vis Sci 52: 8216-8223. doi: 10.1167/iovs.11-8213 PMID: 21948550
20. Ray JL, Leach R, Herbert JM, Benson M (2001) Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 23: 185-188. PMID: 12486328
21. Manceau V, Kremmer E, Nabel EG, Maucuer A (2012) The protein kinase KIS impacts gene expression during development and fear conditioning in adult mice. PLoS One 7: e43946. doi: 10.1371/journal.pone.0043946 PMID: 22937132
22. Monahan TS, Andersen ND, Panossian H, Kalish JA, Daniel S, Shrikhande GV, et al. (2007) A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: modulation of cell migration and proliferation. J Vasc Surg 45: 581-589. PMID: 17321345
23. Yu D, Zhan XH, Zhao XF, Williams MS, Carey GB, Smith E, et al. Mice deficient in MIM expression are predisposed to lymphomagenesis. Oncogene 31: 3561-3568. doi: 10.1038/onc.2011.509 PMID: 22081072
24. Voytik-Harbin SL, Brightman AO, Waisner B, Lamar CH, Badylak SF (1998) Application and evaluation of the alamarBlue assay for cell growth and survival of fibroblasts. In Vitro Cell Dev Biol Anim 34: 239-246. PMID: 9557942
25. Ye W, Mairet-Coello G, DiCicco-Bloom E (2007) DNAse I pre-treatment markedly enhances detection of nuclear cyclin-dependent kinase inhibitor p57Kip2 and BrdU double immunostaining in embryonic rat brain. Histochem Cell Biol 127: 195-203. PMID: 17024454
26. Hakanpaa L, Sipila T, Leppanen VM, Gautam P, Nurmi H, Jacquemet G, et al. (2015) Endothelial destabilization by angiopoietin-2 via integrin beta1 activation. Nat Commun 6: 5962. doi: 10.1038/ncomms6962 PMID: 25635707
27. Aoki T, Sumii T, Mori T, Wang X, Lo EH (2002) Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 33: 2711-2717. PMID: 12411666
28. Tsui LV, Camrud A, Mondesire J, Carlson P, Zayek N, Camrud L, et al. (2001) p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion. Circ Res 89: 323-328. PMID: 11509448
29. Lim Y, Kwon JS, Kim DW, Lee SH, Park RK, Lee JJ, et al. (2010) Obovatol from Magnolia obovata inhibits vascular smooth muscle cell proliferation and intimal hyperplasia by inducing p21Cip1. Atherosclerosis 210: 372-380. doi: 10.1016/j.atherosclerosis.2009.11.037 PMID: 20022323
30. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, et al. (1999) The p21(Cip1) and p27 (Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18: 1571-1583. PMID: 10075928
31. Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, et al. (2002) A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J 21: 3390-3401. PMID: 12093740
32. Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1: 193-199. PMID: 10559916
33. Vlach J, Hennecke S, Amati B (1997) Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 16: 5334-5344. PMID: 9311993
34. Reynisdottir I, Polyak K, Iavarone A, Massague J (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 9: 1831-1845. PMID: 7649471
35. Hirai A, Nakamura S, Noguchi Y, Yasuda T, Kitagawa M, Tatsuno I, et al. (1997) Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J Biol Chem 272: 13-16. PMID: 8995216
36. Alessandrini A, Chiaur DS, Pagano M (1997) Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11: 342-345. PMID: 9067571
37. Shirane M, Harumiya Y, Ishida N, Hirai A, Miyamoto C, Hatakeyama S, et al. (1999) Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 274: 13886-13893. PMID: 10318797
38. Langenickel TH, Olive M, Boehm M, San H, Crook MF, Nabel EG (2008) KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice. J Clin Invest 118: 3848-3859. doi: 10.1172/JCI33206 PMID: 19033656
39. Panetta TF, Sales CM, Marin ML, Schwartz ML, Jones AM, Berdejo GL, et al. (1992) Natural history, duplex characteristics, and histopathologic correlation of arterial injuries in a canine model. J Vasc Surg 16: 867-874; discussion 874-866. PMID: 1460713
40. Wysokinski W, Karnicki K, McBane RD 2nd (2008) Individual propensity for thrombosis: comparison of venous and arterial circulations. Thromb Res 122: 390-396. PMID: 18045663
41. Wysokinski WE, McBane RD 2nd, Owen WG (1999) Individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol 19: 883-886. PMID: 10195913
42. Castronuovo JJ Jr., Price RM (2002) The sequence of gene expression in cultured human saphenous vein after injury. J Vasc Surg 35: 146-151. PMID: 11802146
43. Wang X, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C (2006) Mouse models of neointimal hyperplasia: techniques and applications. Med Sci Monit 12: RA177-185. PMID: 16940942
44. Shuchman M (2006) Trading restenosis for thrombosis? New questions about drug-eluting stents. N Engl J Med 355: 1949-1952. PMID: 17093244
45. Conte MS, Owens CD, Belkin M, Creager MA, Edwards KL, Gasper WJ, et al. (2013) A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts. J Vasc Surg 57: 1179-1185 e1171-1172. doi: 10.1016/j.jvs.2012.11.040 PMID: 23312942